Table 2.
Means and standard deviations.
| End of treatment | Post one week follow up | Post one month follow up | Post six months follow up | |
|---|---|---|---|---|
| FTND | ||||
| TMS & N | 2.31 (2.62) | 1.79 (1.55) | 3.35 (1.97) | 3.71 (2.43) |
| TMS & S | 2.03 (2.08) | 2.04 (2.50) | 2.78 (2.80) | 3.32 (2.74) |
| Placebo | 2.57 (2.69) | 2.64 (2.41) | 3.38 (2.84) | 3.96 (2.57) |
| TCQ-SF | ||||
| TMS & N | 30.93 (17.05) | 29.84 (14.18) | 37.06 (17.94) | 51.52 (19.50) |
| TMS & S | 31.97 (14.61) | 32.17 (21.57) | 30.61 (19.63) | 38.32 (18.22) |
| Placebo | 28.63 (13.10) | 27.28 (14.82) | 35.24 (20.63) | 44.68 (22.34) |
| Motivation to quit smoking | ||||
| TMS & N | 82.41 (20.59) | 72.37 (23.41) | 47.06 (31.72) | 41.67 (34.76) |
| TMS & S | 84.26 (19.79) | 77.17 (30.07) | 70.65 (37.43) | 67.86 (32.53) |
| Placebo | 80.83 (23.38) | 75.00 (27.95) | 52.38 (38.65) | 52.68 (34.92) |
Data are means (standard deviation), averaged over all participants per group. FTND, Fagerström test for Nicotine Dependence; TCQ-SF, Tobacco Craving Questionnaire–Short Form.